CStone Pharmaceuticals, on 13 August 2019, announced the dosing of the first patient in China for the Phase I ...
Ireland based Jazz Pharmaceuticals plc has announced that the Phase 1 study of its recombinant crisantaspase molecu...
DiscGenics, Inc., a US based clinical-stage biotechnology company focused on developing regenerative cell-based therapie...
SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...
Historically, getting patients in clinical trials is the biggest challenge to healthcare breakthrough. But now data can ...
Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm com...
US headquartered Veristat, a scientifically oriented clinical development, and regulatory submission partner, announces ...
CStone Pharmaceuticals has received approval from China National Medical Products Administration (NMPA) to initiate a Ph...
Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that Memorial S...
SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with ...
CStone Pharmaceuticals, on 9 July 2019, announced in Suzhou, China that the first patient has been dosed in Ch...
Sangamo Therapeutics, a genomic medicine company, and Pfizer has announced updated results from the Phase 1/2 ...
Takeda, an R&D-driven, global biopharmaceutical company with a leadership position in rare diseases has announced up...
Sommetrics, a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA) has annou...
XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel s...
Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluati...
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to marke...
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the t...
Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announc...
Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration h...
Boehringer Ingelheim and Eli Lilly and Company have announced results of a new post-hoc analysis of data from the EMPA-R...
Reistone Biopharma Company Limited (Reistone), on 14 June 2019, announced dosing of the first patient in their Phase II ...
Lumosa Therapeutics, on 13 June 2019, announced that the company is ready to commence the Phase 2 proof of concept (PoC)...
Sinovant Sciences announced on 13 June 2019, that its Clinical Trial Application (CTA) for lefamulin has been accepted b...
Terns Pharmaceuticals, Inc. and Shanghai Tuo Zhen Biological Technology Co., Ltd., on 13 June 2019, announced the launch...
Dr. Reddy’s has announced positive topline results from its Phase 2b study of PPC-06 (formerly referred to as...
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for can...
CStone Pharmaceuticals has announced that it has received approval to initiate clinical development in C...
Genentech, a member of the Roche Group has announced that the Phase III BLOCKSTONE study, conducted by Shionogi &am...
Saluda Medical Pty Limited ("Saluda Medical") has announced data from two clinical studies evaluating the performance of...
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines...
Pi Therapeutics, a company dedicated to the development of novel modulators of protein degradation for cancer has announ...
Within the next ten years, up to six new drugs are projected to be approved for the treatment of chronic hepatitis B vir...
The partner of CStone Pharmaceuticals, Agios Pharmaceuticals has announced that the global Phase 3 ClarIDHy trial o...
Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, w...
Growing scientific evidence supports liquid biopsy as a valuable tool for monitoring treatment response in patients with...
Ping An Insurance Company of China has announced that its technology arm, Ping An Technology, has c...
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation,...
AstraZeneca announced positive results from the phase III ASCEND trial of Calquence (acalabrutinib) in previously-treate...
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...
Innovent Biologics and Eli Lilly and Company has jointly announced that IBI301, a recombinant human-mouse...
US based VolitionRx Limited has announced that it has added to its extensive clinical trial programme with the execution...
Asia Pacific is expected to become the destination of choice for clinical trials due to its fast-growing pharmaceutical ...
Tessa Therapeutics, a clinical-stage cell therapy company focused on autologous and allogeneic therapies for a wide rang...
Sinovant Sciences has announced that its Clinical Trial Application (CTA) for derazantinib has been accepted by the...
ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative ...
Collaborative Medicinal Development LLC (CMD) is a privately-held biopharmaceutical company developing innovative therap...
Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the Phase III trials of Desidustat, an Inve...
CStone Pharmaceuticals has announced that the first patient has been successfully enrolled and dosed in Phase III clinic...
CStone Pharmaceuticals has announced that the National Medical Products Administration (NMPA) recently approved the init...
I-Mab Biopharma (I-Mab), a clinical stage biopharmaceutical company exclusively focused on the development of potential ...
George Clinical, a global scientifically backed clinical research organization, (CRO) has expanded its footprint in ...
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety ...
India's leading independent CRO, Veeda Clinical Research Pvt. Ltd. has announced that Bureau Veritas has award...
Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announced that its clinical (Shivalik, Ahmedabad) and B...
Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid ...
WIRB-Copernicus Group has introduced WCG SiteReady, a first-of-its-kind solution aimed at increasing the efficiency and ...
ImmunogenX has announced the initiation of a Phase 2 clinical trial (named Celiac Shield), sponsored by the Nationa...
Bayer presented results from the CHICO part (CHagas disease In Children treated with NifurtimOx) of the phase III clinic...
Global biopharmaceutical company Alvotech has announced that it has enrolled the first patient in its Phase III clinical...
Kezar Life Sciences, a South San Francisco-based clinical-stage biotechnology company discovering and developing n...
iSchemaView, the worldwide leader in advanced imaging for stroke care and research, is proud to announce that iSchemaVie...
Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drug...
Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange has announced tha...
Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing...
Owlstone Medical, a diagnostics company developing a breathalyzer for applications in early disease detection and precis...
Sosei Group Corporation, has announced that the first healthy subject has been dosed with a novel small molecule HTL0030...
Mallinckrodt plc, a leading global specialty pharmaceutical company has announced interim analysis results of its compan...
Saniona, a biotech company focused on CNS and eating disorders has announced the successful completion of preclinical de...
Navitas Life Sciences, a TAKE Solutions Enterprise has announced that it will be acquiring Life Sciences services player...
Boehringer Ingelheim (Canada) Ltd. and IBM Canada have announced at the Healthcare Information and Management Systems So...
Pfizer Inc. and Astellas Pharma Inc. have announced the results from the Phase 3 ARCHES trial in men with metastatic hor...
The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies definin...
Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercializ...
Eisai Co., Ltd. and Purdue Pharma L.P. announced a six-month results from SUNRISE 2, a long-term Phase 3 clinical study ...
Spero Therapeutics, a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...
Ionis Pharma, Inc. the leader in antisense therapeutics, has announced that its partner Roche has enrolled the firs...
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at...
Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the ...
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clin...
Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transfor...
Clinical stage Biopharmaceutical Company, Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National M...
UK based Biotechnology Company, Redx has announced that the UK’s Medicines and Healthcare products Regulatory Agen...
Abcam, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation d...
TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small ...
Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combinat...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...
United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brai...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...
Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development....
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has ...
A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota tr...
A clinical stage pharma company, UroGen Pharma developing treatments to address unmet needs in the field of urology has ...
CellMax Life, a US based diagnostics company with a proprietary technology to detect precancer and cancer cells in blood...
Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the firs...
Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and ...
Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Sol...
Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...
Apellis Pharmaceuticals Inc. has provided an update on the status of its Phase 3 program for APL-2 in patients with...
